fashion -WSS

fashion

author：focus 2025-09-28 02:26:49 - browse：4258

Dozens of sickle cells in a whirlpool — coverage from STAT — Adobe

Nearly a decade ago, consultants delivered to Rodger Novak a kind of Sears catalog of human malady: 200 pages, listing dozens of different diseases, each annotated with — from a business standpoint — their best and worst attributes.

The document was supposed to help Novak, then the chief executive of CRISPR Therapeutics, navigate a pressing quandary. His company, along with two others, were founded to commercialize the new revolutionary gene-editing tool CRISPR-Cas9, which promised to cure numerous genetic diseases. But which should they target first? What was the best proof-of-concept?

“We looked at anything and everything,” said Novak, who stepped down as CEO in 2017 but remained on the board until this year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： AbbVie dramatically boosts its spending on lobbying

hotspot

WSS

How artificial intelligence is being used to detect, treat cancer

White House launches permanent pandemic office

Our daughter's deadly disease: trisomy 18. We wanted to protect her

VC firm General Catalyst wants to buy a health system

Colorectal cancer study finds potential in overlooked immune cell

Why Charlie Gard's case is so disturbing to Americans

focus

fashion

hotspot

Cancer drug shortages should be causing more outrage

Artificial intelligence advances fuel industry trying to preserve loved ones after death

In Memoriam: Notable people who died in 2023

Why Charlie Gard's case is so disturbing to Americans

Dobbs anniversary: the lost opportunity of abortion as health care

Russian special forces kill a gunman who broke into a private house near Moscow

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Senate panel eyes new effort on drug shortages

Malaria cases in Florida and Texas: Here’s what you need to know

AbbVie dramatically boosts its spending on lobbying

leisure time

VC firm General Catalyst wants to buy a health system

Marvel Studios reveals new trailer for 'The Marvels': Watch here

VC firm General Catalyst wants to buy a health system

How artificial intelligence is being used to detect, treat cancer

HIPAA doesn't protect reproductive records from prosecutors

Histogen: Failed biotech offers rare public look inside

focus

hotspot

explore

hotspot